A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
20 January 2015
|
| In: |
European journal of cancer
Year: 2015, Jahrgang: 51, Heft: 4, Pages: 522-532 |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2014.12.019 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1016/j.ejca.2014.12.019
|
| Verfasserangaben: | Manfred Westphal, Oliver Heese, Joachim P. Steinbach, Oliver Schnell, Gabriele Schackert, Maximilian Mehdorn, Dirk Schulz, Matthias Simon, Uwe Schlegel, Christian Senft, Karsten Geletneky, Christian Braun, Joachim G. Hartung, Dirk Reuter, Monika Warmuth Metz, Ferdinand Bach, Torsten Pietsch |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1547495235 | ||
| 003 | DE-627 | ||
| 005 | 20220813054429.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 160927s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejca.2014.12.019 |2 doi | |
| 035 | |a (DE-627)1547495235 | ||
| 035 | |a (DE-576)477495230 | ||
| 035 | |a (DE-599)BSZ477495230 | ||
| 035 | |a (OCoLC)1340931752 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Westphal, Manfred |d 1955- |e VerfasserIn |0 (DE-588)1028398166 |0 (DE-627)730651584 |0 (DE-576)375928790 |4 aut | |
| 245 | 1 | 2 | |a A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma |c Manfred Westphal, Oliver Heese, Joachim P. Steinbach, Oliver Schnell, Gabriele Schackert, Maximilian Mehdorn, Dirk Schulz, Matthias Simon, Uwe Schlegel, Christian Senft, Karsten Geletneky, Christian Braun, Joachim G. Hartung, Dirk Reuter, Monika Warmuth Metz, Ferdinand Bach, Torsten Pietsch |
| 264 | 1 | |c 20 January 2015 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 27.09.2016 | ||
| 700 | 1 | |a Geletneky, Karsten |d 1964- |e VerfasserIn |0 (DE-588)123632862 |0 (DE-627)706375475 |0 (DE-576)293799326 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of cancer |d Amsterdam [u.a.] : Elsevier, 1992 |g 51(2015), 4, Seite 522-532 |w (DE-627)266883400 |w (DE-600)1468190-0 |w (DE-576)090954173 |x 1879-0852 |7 nnas |a A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma |
| 773 | 1 | 8 | |g volume:51 |g year:2015 |g number:4 |g pages:522-532 |g extent:12 |a A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejca.2014.12.019 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20160927 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 123632862 |a Geletneky, Karsten |m 123632862:Geletneky, Karsten |d 910000 |d 911200 |e 910000PG123632862 |e 911200PG123632862 |k 0/910000/ |k 1/910000/911200/ |p 11 | ||
| 999 | |a KXP-PPN1547495235 |e 2939596085 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"12 S."}],"relHost":[{"id":{"issn":["1879-0852"],"eki":["266883400"],"zdb":["1468190-0"]},"origin":[{"dateIssuedDisp":"1992-","dateIssuedKey":"1992","publisher":"Elsevier ; Pergamon Press","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]"}],"titleAlt":[{"title":"EJC online"}],"part":{"extent":"12","volume":"51","text":"51(2015), 4, Seite 522-532","pages":"522-532","issue":"4","year":"2015"},"pubHistory":["28.1992 -"],"recId":"266883400","corporate":[{"roleDisplay":"Herausgebendes Organ","display":"European Organization for Research on Treatment of Cancer","role":"isb"},{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"European Association for Cancer Research"},{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"European School of Oncology"}],"language":["eng"],"disp":"A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastomaEuropean journal of cancer","note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title_sort":"European journal of cancer","title":"European journal of cancer"}]}],"name":{"displayForm":["Manfred Westphal, Oliver Heese, Joachim P. Steinbach, Oliver Schnell, Gabriele Schackert, Maximilian Mehdorn, Dirk Schulz, Matthias Simon, Uwe Schlegel, Christian Senft, Karsten Geletneky, Christian Braun, Joachim G. Hartung, Dirk Reuter, Monika Warmuth Metz, Ferdinand Bach, Torsten Pietsch"]},"origin":[{"dateIssuedDisp":"20 January 2015","dateIssuedKey":"2015"}],"id":{"doi":["10.1016/j.ejca.2014.12.019"],"eki":["1547495235"]},"note":["Gesehen am 27.09.2016"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1547495235","person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Westphal, Manfred","given":"Manfred","family":"Westphal"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Geletneky, Karsten","given":"Karsten","family":"Geletneky"}],"title":[{"title":"A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma","title_sort":"randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma"}]} | ||
| SRT | |a WESTPHALMARANDOMISED2020 | ||